Oxycodoni hydrochloridum, Naloxoni hydrochloridum
| Medicinal product name | Targin 2.5 mg/1.25 mg prolonged-release tablets |
|---|---|
| Pharmaceutical form | Prolonged-release tablet |
| Strength | 2.5 mg/1.25 mg |
| Information from the MAH on shortages |
Not available predicted availability date: not notified |
| Legal status | Prescription (Pr.I) |
| Package leaflet |  15-12-2022
|
| Summary of product characteristics | 23-02-2023
|
| ATC code | N02AA55 – Analgesics |
| Information for Marketing authorisation holders | View |
Medicinal products (11)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Not available (according to the information provided by wholesalers) predicted availability date: not notified |
currently no information on availability from any wholesaler |
N10 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-01 |
 Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-02 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-03 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-04 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-05 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-06 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-07 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-08 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-09 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-10 |
Labelling text Nov 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100: 10 × 10 (2,5 mg/1,25 mg) |
PVC/Al blister | 14-0016-11 |
Labelling text Nov 26, 2020 |
Registration information
| Marketing authorisation No. | 14-0016 |
|---|---|
| Date of authorisation | Jan 20, 2014 |
| Marketing authorisation holder, country | Mundipharma Gesellschaft m.b.H, Austria |
